Association between diabetes mellitus and adverse characteristics of breast cancer at presentation

European Journal of Cancer

Volumn 42, Issue 8, 2006, Pages 1077-1082

  Wolf, Ido ^a,c   Sadetzki, Siegal ^b,c   Gluck, Iris ^a   Oberman, Bernice ^b   Ben David, Merav ^a   Papa, Moshe Zvi ^a,c   Catane, Raphael ^a,c   Kaufman, Bella ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Breast cancer; Diabetes mellitus; Insulin; Oestrogen receptor; Progesterone receptor; Stage

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE; HORMONE RECEPTOR; INSULIN; ORAL ANTIDIABETIC AGENT; TAMOXIFEN;

ADULT; AGED; ARTICLE; BIRTH; BODY MASS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC TEST; DIET THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PARITY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 33646433412     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.01.027     Document Type: Article

References (34)

1. Mokdad A.H., Ford E.S., Bowman B.A., et al. Diabetes trends in the U.S.: 1990-1998. Diabetes Care 23 (2000) 1278-1283
2. Saltiel A.R. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104 (2001) 517-529
3. Adami H.O., McLaughlin J., Ekbom A., et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2 (1991) 307-314
4. Meyerhardt J.A., Catalano P.J., Haller D.G., et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 21 (2003) 433-440
5. Sperti C., Pasquali C., Piccoli A., and Pedrazzoli S. Survival after resection for ductal adenocarcinoma of the pancreas. Brit J Surg 83 (1996) 625-631
6. Toyoda H., Kumada T., Nakano S., et al. Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma. Cancer 91 (2001) 957-963
7. Key T.J., Verkasalo P.K., and Banks E. Epidemiology of breast cancer. Lancet Oncol 2 (2001) 133-140
8. Coebergh J.W., Janssen-Heijnen M.L., Post P.N., and Razenberg P.P. Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993-1996. J Clin Epidemiol 52 (1999) 1131-1136
9. Weiderpass E., Gridley G., Persson I., Nyren O., Ekbom A., and Adami H.O. Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 71 (1997) 360-363
10. Wideroff L., Gridley G., Mellemkjaer L., et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89 (1997) 1360-1365
11. Michels K.B., Solomon C.G., Hu F.B., et al. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 26 (2003) 1752-1758
12. Wolf I., Sadetzki S., Catane R., Karasik A., and Kaufman B. Diabetes mellitus and breast cancer. Lancet Oncol 6 (2005) 103-111
13. Friedenreich C.M. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 10 (2001) 15-32
14. Bianchini F., Kaaks R., and Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 3 (2002) 565-574
15. Banks E., Beral V., Cameron R., et al. Comparison of various characteristics of women who do and do not attend for breast cancer screening. Breast Cancer Res 4 (2002) R1
16. Beckman T.J., Cuddihy R.M., Scheitel S.M., Naessens J.M., Killian J.M., and Pankratz V.S. Screening mammogram utilization in women with diabetes. Diabetes Care 24 (2001) 2049-2053
17. Yancik R., Wesley M.N., Ries L.A., Havlik R.J., Edwards B.K., and Yates J.W. Effect of age and co-morbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285 (2001) 885-892
18. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
19. In: Fleming I.D., Cooper J.S., and Henson D.E. (Eds). Breast cancer. 5th ed. American Joint Committee on Cancer Staging Manual (1997), Lippincott-Raven, Philadelphia (PA)
20. Extermann M. Measuring co-morbidity in older cancer patients. Eur J Cancer 36 (2000) 453-471
21. Bundred N.J. Prognostic and predictive factors in breast cancer. Cancer Treat Rev 27 (2001) 137-142
22. The Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective Studies. J Natl Cancer Inst 94 (2002) 606-616
23. Nyholm H., Djursing H., Hagen C., et al. Androgens and estrogens in postmenopausal insulin-treated diabetic women. J Clin Endocrinol Metab 69 (1989) 946-949
24. Sachdev D., and Yee D. The IGF system and breast cancer. Endocr Relat Cancer 8 (2001) 197-209
25. Hankinson S.E., Willett W.C., Colditz G.A., et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351 (1998) 1393-1396
26. Mohamed-Ali V., Pinkney J.H., Panahloo A., Cwyfan-Hughes S., Holly J.M., and Yudkin J.S. Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome. Clin Endocrinol 50 (1999) 221-228
27. Chappell J., Leitner J.W., Solomon S., Golovchenko I., Goalstone M.L., and Draznin B. Effect of insulin on cell cycle progression in MCF-7 breast cancer cells. Direct and potentiating influence. J Biol Chem 276 (2001) 38023-38028
28. Papa V., Pezzino V., Costantino A., et al. Elevated insulin receptor content in human breast cancer. J Clin Invest 86 (1990) 1503-1510
29. Belfiore A., Frittitta L., Costantino A., et al. Insulin receptors in breast cancer. Ann N Y Acad Sci 784 (1996) 173-188
30. Goodwin P.J., Ennis M., Pritchard K.I., et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20 (2002) 42-51
31. Velanovich V., Gabel M., Walker E.M., et al. Causes for the undertreatment of elderly breast cancer patients: tailoring treatments to individual patients. J Am Coll Surg 194 (2002) 8-13
32. Hebert-Croteau N., Brisson J., Latreille J., Blanchette C., and Deschenes L. Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 85 (1999) 1104-1113
33. Ballard-Barbash R., Potosky A.L., Harlan L.C., Nayfield S.G., and Kessler L.G. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 88 (1996) 716-726
34. Goldhirsch A., Glick J.H., Gelber R.D., Coates A.S., and Senn H.J. Meeting highlights: international consensus panel on the treatment of primary breast cancer. seventh international conference on adjuvant therapy of primary breast cancer. J Clin Oncol 19 (2001) 3817-3827